Replies to post #422250 on NorthWest Biotherapeutics Inc (NWBO)

[scotty3371]

The demographic profile of dcvax trial, most notable being 64 average age; I would guess 5 years is maybe 1%, so one might conclude dcvax.......

[sukus]

Key info for comparison Flip to make better decision. Looks like the OS number at 5 year between SOC and treatment under the new WHO definition would be 3% SOC and 20% treatment. I believe DCvax-L knocked out SOC.